23Andme Holding Co. Grants New FDA Clearance to Report Additional BRCA Variants

23andMe Holding Co. announced the Company has received a U.S. Food and Drug Administration 510 clearance to expand its existing BRCA1/BRCA2 Genetic Health Risk Report. The clearance allows 23andMe...

Related Keywords

United States ,American , ,Genetic Health Risk ,Sme Health ,Drug Administration ,Ancestry Service ,Variants Genetic Health Risk ,Genome Service ,Me Holding Co ,Selected Variants ,Ashkenazi Jewish ,African American ,Predetermined Change Control Plan ,Submission Recommendations ,Machine Learning Enabled Device Software ,Ashkenazi European ,East Asian ,Genetic Health Risk Report ,Personal Genome ,Markets ,